Impact of Class Ii Hla Mismatch on Clinical Outcomes in Hodgkin Lymphoma Patients Receiving Haploidentical Stem Cell Transplantation (Haplo-Sct) With Post-Transplant Cyclophosphamide (Pt-Cy)
Hematological Oncology - United Kingdom
doi 10.1002/hon.109_2630
Full Text
Open PDFAbstract
Available in full text
Date
June 1, 2019
Authors
Publisher
Wiley